Asthma drug zafirlukast (Accolate): serious hepatic events.
about
The effects of zafirlukast on capsular contracture: preliminary reportThe preventive effect of topical zafirlukast instillation for peri-implant capsule formation in rabbits.Value of preapproval safety data in predicting postapproval hepatic safety and assessing the legitimacy of class warning.Ethnic differences in adverse drug reactions to asthma medications: a systematic review.Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
P2860
Asthma drug zafirlukast (Accolate): serious hepatic events.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Asthma drug zafirlukast (Accolate): serious hepatic events.
@en
Asthma drug zafirlukast
@nl
type
label
Asthma drug zafirlukast (Accolate): serious hepatic events.
@en
Asthma drug zafirlukast
@nl
prefLabel
Asthma drug zafirlukast (Accolate): serious hepatic events.
@en
Asthma drug zafirlukast
@nl
P356
P1476
Asthma drug zafirlukast (Accolate): serious hepatic events.
@en
P2093
Eric Wooltorton
P356
10.1503/CMAJ.1040720
P407
P577
2004-05-01T00:00:00Z